Loading…

Comparison of the Efficacy of Homologous and Autologous Platelet-Rich Plasma (PRP) for Treating Androgenic Alopecia

Background Androgenetic alopecia (AGA), the most common cause of hair loss in both sexes, accounts for 95% of all cases of hair loss. Although the literature has suggested that both nonactivated (n-PRP) and activated autologous (a-PRP) PRP can be used to treat AGA, we did not find any study investig...

Full description

Saved in:
Bibliographic Details
Published in:Aesthetic plastic surgery 2018-02, Vol.42 (1), p.297-303
Main Authors: Ince, Bilsev, Yildirim, Mehmet Emin Cem, Dadaci, Mehmet, Avunduk, Mustafa Cihat, Savaci, Nedim
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c372t-1ef240061205c442dc5433919e0c0473ecedbb1101d588b6a85f5feed34ae6d23
cites cdi_FETCH-LOGICAL-c372t-1ef240061205c442dc5433919e0c0473ecedbb1101d588b6a85f5feed34ae6d23
container_end_page 303
container_issue 1
container_start_page 297
container_title Aesthetic plastic surgery
container_volume 42
creator Ince, Bilsev
Yildirim, Mehmet Emin Cem
Dadaci, Mehmet
Avunduk, Mustafa Cihat
Savaci, Nedim
description Background Androgenetic alopecia (AGA), the most common cause of hair loss in both sexes, accounts for 95% of all cases of hair loss. Although the literature has suggested that both nonactivated (n-PRP) and activated autologous (a-PRP) PRP can be used to treat AGA, we did not find any study investigating the use of homologous PRP (h-PRP) for this purpose. Also, to the best of our knowledge, there are no studies comparing the efficacy of h-PRP, a-PRP, or n-PRP on AGA therapy. Objectives The aim of this study was to compare the increase in hair density, average number of platelets, complications, preparation, and duration of application in the treatment of AGA using a-PRP, n-PRP, and h-PRP. Methods Between 2014 and 2015, we studied male patients who had experienced increased hair loss in the last year. Patients were divided into three groups: Group 1 received n-PRP, Group 2 received active PRP, and Group 3 received h-PRP. For Group 1, PRP was prepared by a single centrifugation prepared from the patient’s own blood. For Group 2, the PRP was prepared from the patient’s own blood, but a second centrifugation was applied for platelet activation with calcium chloride. For Group 3, the PRP was prepared from pooled platelets with the same blood group as the patient from the blood center. PRP was injected at 1, 2, and 6 months. The hair density (n/cm 2 ) of each patient before and after injection was calculated. Each patient was assigned a fixed evaluation point at the time of application to calculate hair density. Results At 2, 6, and 12 months after the first treatment, the increase in hair density was calculated as 11.2, 26.1, and 32.4%, respectively, in Group 1; 8.1, 12.5, and 20.8%, respectively, in Group 2; and 16.09, 36.41, and 41.76%, respectively, in Group 3. The increase in hair density was statistically significantly greater in Group 1 than in Group 2 and more so in Group 3 than in both groups among all controls ( p  
doi_str_mv 10.1007/s00266-017-1004-y
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1960925676</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1993458789</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-1ef240061205c442dc5433919e0c0473ecedbb1101d588b6a85f5feed34ae6d23</originalsourceid><addsrcrecordid>eNp1kc1KJDEUhcOgjK0zDzCbIeBGF9Gbn0qqlk3jHwg24sDsinTqpi2pqvQkVYt-e9O0yiC4Ch_57kkuh5BfHC44gLlMAEJrBtywzIptv5EZV1KwQih-QGYgtWKC679H5DilFwAujFHfyZGoOGTRzEhahH5jY5vCQIOn4zPSK-9bZ912x7ehD11YhylROzR0Po3vuOzsiB2O7LF1zztKvaVny8flOfUh0qeIdmyHNZ0PTQxrHFpH513YoGvtD3LobZfw59t5Qv5cXz0tbtn9w83dYn7PnDRiZBy9UACaCyicUqJxhZKy4hWCA2UkOmxWK543aYqyXGlbFr7wiI1UFnUj5Ak52-duYvg3YRrrvk0Ou84OmFeoeaWhEoU2Oqunn9SXMMUh_y5blVRFacoqW3xvuRhSiujrTWx7G7c1h3rXSL1vpM6N7FjV2zzz-y15WvXYfEy8V5AFsRdSvhrWGP97-svUV5cclg4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1993458789</pqid></control><display><type>article</type><title>Comparison of the Efficacy of Homologous and Autologous Platelet-Rich Plasma (PRP) for Treating Androgenic Alopecia</title><source>Springer Nature</source><creator>Ince, Bilsev ; Yildirim, Mehmet Emin Cem ; Dadaci, Mehmet ; Avunduk, Mustafa Cihat ; Savaci, Nedim</creator><creatorcontrib>Ince, Bilsev ; Yildirim, Mehmet Emin Cem ; Dadaci, Mehmet ; Avunduk, Mustafa Cihat ; Savaci, Nedim</creatorcontrib><description>Background Androgenetic alopecia (AGA), the most common cause of hair loss in both sexes, accounts for 95% of all cases of hair loss. Although the literature has suggested that both nonactivated (n-PRP) and activated autologous (a-PRP) PRP can be used to treat AGA, we did not find any study investigating the use of homologous PRP (h-PRP) for this purpose. Also, to the best of our knowledge, there are no studies comparing the efficacy of h-PRP, a-PRP, or n-PRP on AGA therapy. Objectives The aim of this study was to compare the increase in hair density, average number of platelets, complications, preparation, and duration of application in the treatment of AGA using a-PRP, n-PRP, and h-PRP. Methods Between 2014 and 2015, we studied male patients who had experienced increased hair loss in the last year. Patients were divided into three groups: Group 1 received n-PRP, Group 2 received active PRP, and Group 3 received h-PRP. For Group 1, PRP was prepared by a single centrifugation prepared from the patient’s own blood. For Group 2, the PRP was prepared from the patient’s own blood, but a second centrifugation was applied for platelet activation with calcium chloride. For Group 3, the PRP was prepared from pooled platelets with the same blood group as the patient from the blood center. PRP was injected at 1, 2, and 6 months. The hair density (n/cm 2 ) of each patient before and after injection was calculated. Each patient was assigned a fixed evaluation point at the time of application to calculate hair density. Results At 2, 6, and 12 months after the first treatment, the increase in hair density was calculated as 11.2, 26.1, and 32.4%, respectively, in Group 1; 8.1, 12.5, and 20.8%, respectively, in Group 2; and 16.09, 36.41, and 41.76%, respectively, in Group 3. The increase in hair density was statistically significantly greater in Group 1 than in Group 2 and more so in Group 3 than in both groups among all controls ( p  &lt; 0.05). Conclusion The efficacy of both PRPs was determined in AGA treatment in our study. However, it was determined statistically that the increase in hair density with h-PRP was greater than with autologous PRP groups. We believe that h-PRP therapy can be used in patients with AGA presenting with hair loss. Level of Evidence II This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .</description><identifier>ISSN: 0364-216X</identifier><identifier>EISSN: 1432-5241</identifier><identifier>DOI: 10.1007/s00266-017-1004-y</identifier><identifier>PMID: 29101437</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; Alopecia - diagnosis ; Alopecia - therapy ; Baldness ; Cohort Studies ; Hair - growth &amp; development ; Hair loss ; Humans ; Injections, Intralesional ; Male ; Medicine ; Medicine &amp; Public Health ; Original Article ; Otorhinolaryngology ; Patients ; Plastic Surgery ; Platelet-Rich Plasma ; Prospective Studies ; Sensitivity and Specificity ; Transplantation, Autologous - methods ; Transplantation, Homologous - methods</subject><ispartof>Aesthetic plastic surgery, 2018-02, Vol.42 (1), p.297-303</ispartof><rights>Springer Science+Business Media, LLC and International Society of Aesthetic Plastic Surgery 2017</rights><rights>Aesthetic Plastic Surgery is a copyright of Springer, (2017). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-1ef240061205c442dc5433919e0c0473ecedbb1101d588b6a85f5feed34ae6d23</citedby><cites>FETCH-LOGICAL-c372t-1ef240061205c442dc5433919e0c0473ecedbb1101d588b6a85f5feed34ae6d23</cites><orcidid>0000-0002-1756-4131</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29101437$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ince, Bilsev</creatorcontrib><creatorcontrib>Yildirim, Mehmet Emin Cem</creatorcontrib><creatorcontrib>Dadaci, Mehmet</creatorcontrib><creatorcontrib>Avunduk, Mustafa Cihat</creatorcontrib><creatorcontrib>Savaci, Nedim</creatorcontrib><title>Comparison of the Efficacy of Homologous and Autologous Platelet-Rich Plasma (PRP) for Treating Androgenic Alopecia</title><title>Aesthetic plastic surgery</title><addtitle>Aesth Plast Surg</addtitle><addtitle>Aesthetic Plast Surg</addtitle><description>Background Androgenetic alopecia (AGA), the most common cause of hair loss in both sexes, accounts for 95% of all cases of hair loss. Although the literature has suggested that both nonactivated (n-PRP) and activated autologous (a-PRP) PRP can be used to treat AGA, we did not find any study investigating the use of homologous PRP (h-PRP) for this purpose. Also, to the best of our knowledge, there are no studies comparing the efficacy of h-PRP, a-PRP, or n-PRP on AGA therapy. Objectives The aim of this study was to compare the increase in hair density, average number of platelets, complications, preparation, and duration of application in the treatment of AGA using a-PRP, n-PRP, and h-PRP. Methods Between 2014 and 2015, we studied male patients who had experienced increased hair loss in the last year. Patients were divided into three groups: Group 1 received n-PRP, Group 2 received active PRP, and Group 3 received h-PRP. For Group 1, PRP was prepared by a single centrifugation prepared from the patient’s own blood. For Group 2, the PRP was prepared from the patient’s own blood, but a second centrifugation was applied for platelet activation with calcium chloride. For Group 3, the PRP was prepared from pooled platelets with the same blood group as the patient from the blood center. PRP was injected at 1, 2, and 6 months. The hair density (n/cm 2 ) of each patient before and after injection was calculated. Each patient was assigned a fixed evaluation point at the time of application to calculate hair density. Results At 2, 6, and 12 months after the first treatment, the increase in hair density was calculated as 11.2, 26.1, and 32.4%, respectively, in Group 1; 8.1, 12.5, and 20.8%, respectively, in Group 2; and 16.09, 36.41, and 41.76%, respectively, in Group 3. The increase in hair density was statistically significantly greater in Group 1 than in Group 2 and more so in Group 3 than in both groups among all controls ( p  &lt; 0.05). Conclusion The efficacy of both PRPs was determined in AGA treatment in our study. However, it was determined statistically that the increase in hair density with h-PRP was greater than with autologous PRP groups. We believe that h-PRP therapy can be used in patients with AGA presenting with hair loss. Level of Evidence II This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .</description><subject>Adult</subject><subject>Alopecia - diagnosis</subject><subject>Alopecia - therapy</subject><subject>Baldness</subject><subject>Cohort Studies</subject><subject>Hair - growth &amp; development</subject><subject>Hair loss</subject><subject>Humans</subject><subject>Injections, Intralesional</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Original Article</subject><subject>Otorhinolaryngology</subject><subject>Patients</subject><subject>Plastic Surgery</subject><subject>Platelet-Rich Plasma</subject><subject>Prospective Studies</subject><subject>Sensitivity and Specificity</subject><subject>Transplantation, Autologous - methods</subject><subject>Transplantation, Homologous - methods</subject><issn>0364-216X</issn><issn>1432-5241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kc1KJDEUhcOgjK0zDzCbIeBGF9Gbn0qqlk3jHwg24sDsinTqpi2pqvQkVYt-e9O0yiC4Ch_57kkuh5BfHC44gLlMAEJrBtywzIptv5EZV1KwQih-QGYgtWKC679H5DilFwAujFHfyZGoOGTRzEhahH5jY5vCQIOn4zPSK-9bZ912x7ehD11YhylROzR0Po3vuOzsiB2O7LF1zztKvaVny8flOfUh0qeIdmyHNZ0PTQxrHFpH513YoGvtD3LobZfw59t5Qv5cXz0tbtn9w83dYn7PnDRiZBy9UACaCyicUqJxhZKy4hWCA2UkOmxWK543aYqyXGlbFr7wiI1UFnUj5Ak52-duYvg3YRrrvk0Ou84OmFeoeaWhEoU2Oqunn9SXMMUh_y5blVRFacoqW3xvuRhSiujrTWx7G7c1h3rXSL1vpM6N7FjV2zzz-y15WvXYfEy8V5AFsRdSvhrWGP97-svUV5cclg4</recordid><startdate>20180201</startdate><enddate>20180201</enddate><creator>Ince, Bilsev</creator><creator>Yildirim, Mehmet Emin Cem</creator><creator>Dadaci, Mehmet</creator><creator>Avunduk, Mustafa Cihat</creator><creator>Savaci, Nedim</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1756-4131</orcidid></search><sort><creationdate>20180201</creationdate><title>Comparison of the Efficacy of Homologous and Autologous Platelet-Rich Plasma (PRP) for Treating Androgenic Alopecia</title><author>Ince, Bilsev ; Yildirim, Mehmet Emin Cem ; Dadaci, Mehmet ; Avunduk, Mustafa Cihat ; Savaci, Nedim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-1ef240061205c442dc5433919e0c0473ecedbb1101d588b6a85f5feed34ae6d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Alopecia - diagnosis</topic><topic>Alopecia - therapy</topic><topic>Baldness</topic><topic>Cohort Studies</topic><topic>Hair - growth &amp; development</topic><topic>Hair loss</topic><topic>Humans</topic><topic>Injections, Intralesional</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Original Article</topic><topic>Otorhinolaryngology</topic><topic>Patients</topic><topic>Plastic Surgery</topic><topic>Platelet-Rich Plasma</topic><topic>Prospective Studies</topic><topic>Sensitivity and Specificity</topic><topic>Transplantation, Autologous - methods</topic><topic>Transplantation, Homologous - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ince, Bilsev</creatorcontrib><creatorcontrib>Yildirim, Mehmet Emin Cem</creatorcontrib><creatorcontrib>Dadaci, Mehmet</creatorcontrib><creatorcontrib>Avunduk, Mustafa Cihat</creatorcontrib><creatorcontrib>Savaci, Nedim</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Aesthetic plastic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ince, Bilsev</au><au>Yildirim, Mehmet Emin Cem</au><au>Dadaci, Mehmet</au><au>Avunduk, Mustafa Cihat</au><au>Savaci, Nedim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of the Efficacy of Homologous and Autologous Platelet-Rich Plasma (PRP) for Treating Androgenic Alopecia</atitle><jtitle>Aesthetic plastic surgery</jtitle><stitle>Aesth Plast Surg</stitle><addtitle>Aesthetic Plast Surg</addtitle><date>2018-02-01</date><risdate>2018</risdate><volume>42</volume><issue>1</issue><spage>297</spage><epage>303</epage><pages>297-303</pages><issn>0364-216X</issn><eissn>1432-5241</eissn><abstract>Background Androgenetic alopecia (AGA), the most common cause of hair loss in both sexes, accounts for 95% of all cases of hair loss. Although the literature has suggested that both nonactivated (n-PRP) and activated autologous (a-PRP) PRP can be used to treat AGA, we did not find any study investigating the use of homologous PRP (h-PRP) for this purpose. Also, to the best of our knowledge, there are no studies comparing the efficacy of h-PRP, a-PRP, or n-PRP on AGA therapy. Objectives The aim of this study was to compare the increase in hair density, average number of platelets, complications, preparation, and duration of application in the treatment of AGA using a-PRP, n-PRP, and h-PRP. Methods Between 2014 and 2015, we studied male patients who had experienced increased hair loss in the last year. Patients were divided into three groups: Group 1 received n-PRP, Group 2 received active PRP, and Group 3 received h-PRP. For Group 1, PRP was prepared by a single centrifugation prepared from the patient’s own blood. For Group 2, the PRP was prepared from the patient’s own blood, but a second centrifugation was applied for platelet activation with calcium chloride. For Group 3, the PRP was prepared from pooled platelets with the same blood group as the patient from the blood center. PRP was injected at 1, 2, and 6 months. The hair density (n/cm 2 ) of each patient before and after injection was calculated. Each patient was assigned a fixed evaluation point at the time of application to calculate hair density. Results At 2, 6, and 12 months after the first treatment, the increase in hair density was calculated as 11.2, 26.1, and 32.4%, respectively, in Group 1; 8.1, 12.5, and 20.8%, respectively, in Group 2; and 16.09, 36.41, and 41.76%, respectively, in Group 3. The increase in hair density was statistically significantly greater in Group 1 than in Group 2 and more so in Group 3 than in both groups among all controls ( p  &lt; 0.05). Conclusion The efficacy of both PRPs was determined in AGA treatment in our study. However, it was determined statistically that the increase in hair density with h-PRP was greater than with autologous PRP groups. We believe that h-PRP therapy can be used in patients with AGA presenting with hair loss. Level of Evidence II This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .</abstract><cop>New York</cop><pub>Springer US</pub><pmid>29101437</pmid><doi>10.1007/s00266-017-1004-y</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-1756-4131</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0364-216X
ispartof Aesthetic plastic surgery, 2018-02, Vol.42 (1), p.297-303
issn 0364-216X
1432-5241
language eng
recordid cdi_proquest_miscellaneous_1960925676
source Springer Nature
subjects Adult
Alopecia - diagnosis
Alopecia - therapy
Baldness
Cohort Studies
Hair - growth & development
Hair loss
Humans
Injections, Intralesional
Male
Medicine
Medicine & Public Health
Original Article
Otorhinolaryngology
Patients
Plastic Surgery
Platelet-Rich Plasma
Prospective Studies
Sensitivity and Specificity
Transplantation, Autologous - methods
Transplantation, Homologous - methods
title Comparison of the Efficacy of Homologous and Autologous Platelet-Rich Plasma (PRP) for Treating Androgenic Alopecia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T19%3A45%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20the%20Efficacy%20of%20Homologous%20and%20Autologous%20Platelet-Rich%20Plasma%20(PRP)%20for%20Treating%20Androgenic%20Alopecia&rft.jtitle=Aesthetic%20plastic%20surgery&rft.au=Ince,%20Bilsev&rft.date=2018-02-01&rft.volume=42&rft.issue=1&rft.spage=297&rft.epage=303&rft.pages=297-303&rft.issn=0364-216X&rft.eissn=1432-5241&rft_id=info:doi/10.1007/s00266-017-1004-y&rft_dat=%3Cproquest_cross%3E1993458789%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-1ef240061205c442dc5433919e0c0473ecedbb1101d588b6a85f5feed34ae6d23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1993458789&rft_id=info:pmid/29101437&rfr_iscdi=true